awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q40037876-4EF8623E-DBB3-4C4F-9B6D-74AFA93E7BE8
Q40037876-4EF8623E-DBB3-4C4F-9B6D-74AFA93E7BE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40037876-4EF8623E-DBB3-4C4F-9B6D-74AFA93E7BE8
CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgki
P2860
Q40037876-4EF8623E-DBB3-4C4F-9B6D-74AFA93E7BE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40037876-4EF8623E-DBB3-4C4F-9B6D-74AFA93E7BE8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f8e5e57f563c3ba2abda97e214388397d25627c6
P2860
Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas.